Intravenous Immunoglobulin (IVIg) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Intravenous Immunoglobulin (IVIg) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Intravenous Immunoglobulin (IVIg) market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Intravenous Immunoglobulin (IVIg) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Intravenous Immunoglobulin (IVIg) market segmented into
- Immunodeficiency
- IVIg Powder
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Baxter
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) INDUSTRY
2.1 Summary about Intravenous Immunoglobulin (IVIg) Industry
2.2 Intravenous Immunoglobulin (IVIg) Market Trends
2.2.1 Intravenous Immunoglobulin (IVIg) Production & Consumption Trends
2.2.2 Intravenous Immunoglobulin (IVIg) Demand Structure Trends
2.3 Intravenous Immunoglobulin (IVIg) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 IVIg Liquid
4.2.2 IVIg Powder
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Immunodeficiency
4.3.2 Autoimmune Disease
4.3.3 Acute Infection
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 IVIg Liquid
5.2.2 IVIg Powder
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Immunodeficiency
5.3.2 Autoimmune Disease
5.3.3 Acute Infection
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 IVIg Liquid
6.2.2 IVIg Powder
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Immunodeficiency
6.3.2 Autoimmune Disease
6.3.3 Acute Infection
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 IVIg Liquid
7.2.2 IVIg Powder
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Immunodeficiency
7.3.2 Autoimmune Disease
7.3.3 Acute Infection
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 IVIg Liquid
8.2.2 IVIg Powder
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Immunodeficiency
8.3.2 Autoimmune Disease
8.3.3 Acute Infection
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 IVIg Liquid
9.2.2 IVIg Powder
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Immunodeficiency
9.3.2 Autoimmune Disease
9.3.3 Acute Infection
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Baxter
10.1.2 Grifols
10.1.3 CSL
10.1.4 Octapharma
10.1.5 Biotest
10.1.6 Kedrion
10.1.7 Hualan Bio
10.1.8 CNBG
10.1.9 Shanghai RAAS
10.1.10 CBPO
10.1.11 LFB Group
10.1.12 BPL
10.1.13 Sichuan Yuanda Shuyang
10.2 Intravenous Immunoglobulin (IVIg) Sales Date of Major Players (2017-2020e)
10.2.1 Baxter
10.2.2 Grifols
10.2.3 CSL
10.2.4 Octapharma
10.2.5 Biotest
10.2.6 Kedrion
10.2.7 Hualan Bio
10.2.8 CNBG
10.2.9 Shanghai RAAS
10.2.10 CBPO
10.2.11 LFB Group
10.2.12 BPL
10.2.13 Sichuan Yuanda Shuyang
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) INDUSTRY
2.1 Summary about Intravenous Immunoglobulin (IVIg) Industry
2.2 Intravenous Immunoglobulin (IVIg) Market Trends
2.2.1 Intravenous Immunoglobulin (IVIg) Production & Consumption Trends
2.2.2 Intravenous Immunoglobulin (IVIg) Demand Structure Trends
2.3 Intravenous Immunoglobulin (IVIg) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 IVIg Liquid
4.2.2 IVIg Powder
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Immunodeficiency
4.3.2 Autoimmune Disease
4.3.3 Acute Infection
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 IVIg Liquid
5.2.2 IVIg Powder
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Immunodeficiency
5.3.2 Autoimmune Disease
5.3.3 Acute Infection
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 IVIg Liquid
6.2.2 IVIg Powder
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Immunodeficiency
6.3.2 Autoimmune Disease
6.3.3 Acute Infection
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 IVIg Liquid
7.2.2 IVIg Powder
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Immunodeficiency
7.3.2 Autoimmune Disease
7.3.3 Acute Infection
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 IVIg Liquid
8.2.2 IVIg Powder
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Immunodeficiency
8.3.2 Autoimmune Disease
8.3.3 Acute Infection
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 IVIg Liquid
9.2.2 IVIg Powder
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Immunodeficiency
9.3.2 Autoimmune Disease
9.3.3 Acute Infection
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Baxter
10.1.2 Grifols
10.1.3 CSL
10.1.4 Octapharma
10.1.5 Biotest
10.1.6 Kedrion
10.1.7 Hualan Bio
10.1.8 CNBG
10.1.9 Shanghai RAAS
10.1.10 CBPO
10.1.11 LFB Group
10.1.12 BPL
10.1.13 Sichuan Yuanda Shuyang
10.2 Intravenous Immunoglobulin (IVIg) Sales Date of Major Players (2017-2020e)
10.2.1 Baxter
10.2.2 Grifols
10.2.3 CSL
10.2.4 Octapharma
10.2.5 Biotest
10.2.6 Kedrion
10.2.7 Hualan Bio
10.2.8 CNBG
10.2.9 Shanghai RAAS
10.2.10 CBPO
10.2.11 LFB Group
10.2.12 BPL
10.2.13 Sichuan Yuanda Shuyang
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Intravenous Immunoglobulin (IVIg) Product Type Overview
2.Table Intravenous Immunoglobulin (IVIg) Product Type Market Share List
3.Table Intravenous Immunoglobulin (IVIg) Product Type of Major Players
4.Table Brief Introduction of Baxter
5.Table Brief Introduction of Grifols
6.Table Brief Introduction of CSL
7.Table Brief Introduction of Octapharma
8.Table Brief Introduction of Biotest
9.Table Brief Introduction of Kedrion
10.Table Brief Introduction of Hualan Bio
11.Table Brief Introduction of CNBG
12.Table Brief Introduction of Shanghai RAAS
13.Table Brief Introduction of CBPO
14.Table Brief Introduction of LFB Group
15.Table Brief Introduction of BPL
16.Table Brief Introduction of Sichuan Yuanda Shuyang
17.Table Products & Services of Baxter
18.Table Products & Services of Grifols
19.Table Products & Services of CSL
20.Table Products & Services of Octapharma
21.Table Products & Services of Biotest
22.Table Products & Services of Kedrion
23.Table Products & Services of Hualan Bio
24.Table Products & Services of CNBG
25.Table Products & Services of Shanghai RAAS
26.Table Products & Services of CBPO
27.Table Products & Services of LFB Group
28.Table Products & Services of BPL
29.Table Products & Services of Sichuan Yuanda Shuyang
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Intravenous Immunoglobulin (IVIg) Product Type Overview
2.Table Intravenous Immunoglobulin (IVIg) Product Type Market Share List
3.Table Intravenous Immunoglobulin (IVIg) Product Type of Major Players
4.Table Brief Introduction of Baxter
5.Table Brief Introduction of Grifols
6.Table Brief Introduction of CSL
7.Table Brief Introduction of Octapharma
8.Table Brief Introduction of Biotest
9.Table Brief Introduction of Kedrion
10.Table Brief Introduction of Hualan Bio
11.Table Brief Introduction of CNBG
12.Table Brief Introduction of Shanghai RAAS
13.Table Brief Introduction of CBPO
14.Table Brief Introduction of LFB Group
15.Table Brief Introduction of BPL
16.Table Brief Introduction of Sichuan Yuanda Shuyang
17.Table Products & Services of Baxter
18.Table Products & Services of Grifols
19.Table Products & Services of CSL
20.Table Products & Services of Octapharma
21.Table Products & Services of Biotest
22.Table Products & Services of Kedrion
23.Table Products & Services of Hualan Bio
24.Table Products & Services of CNBG
25.Table Products & Services of Shanghai RAAS
26.Table Products & Services of CBPO
27.Table Products & Services of LFB Group
28.Table Products & Services of BPL
29.Table Products & Services of Sichuan Yuanda Shuyang
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Intravenous Immunoglobulin (IVIg) Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Intravenous Immunoglobulin (IVIg) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Intravenous Immunoglobulin (IVIg) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Intravenous Immunoglobulin (IVIg) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Intravenous Immunoglobulin (IVIg) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Intravenous Immunoglobulin (IVIg) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Intravenous Immunoglobulin (IVIg) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Intravenous Immunoglobulin (IVIg) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Baxter 2017-2020e
66.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Grifols 2017-2020e
67.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of CSL 2017-2020e
68.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Octapharma 2017-2020e
69.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Biotest 2017-2020e
70.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Kedrion 2017-2020e
71.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Hualan Bio 2017-2020e
72.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of CNBG 2017-2020e
73.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Shanghai RAAS 2017-2020e
74.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of CBPO 2017-2020e
75.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of LFB Group 2017-2020e
76.Figure Intravenous Immunoglob
1.Figure Global Intravenous Immunoglobulin (IVIg) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Intravenous Immunoglobulin (IVIg) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Intravenous Immunoglobulin (IVIg) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Intravenous Immunoglobulin (IVIg) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Intravenous Immunoglobulin (IVIg) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Intravenous Immunoglobulin (IVIg) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Intravenous Immunoglobulin (IVIg) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure IVIg Liquid Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure IVIg Powder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Immunodeficiency Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Autoimmune Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Acute Infection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Baxter 2017-2020e
66.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Grifols 2017-2020e
67.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of CSL 2017-2020e
68.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Octapharma 2017-2020e
69.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Biotest 2017-2020e
70.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Kedrion 2017-2020e
71.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Hualan Bio 2017-2020e
72.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of CNBG 2017-2020e
73.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of Shanghai RAAS 2017-2020e
74.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of CBPO 2017-2020e
75.Figure Intravenous Immunoglobulin (IVIg) Sales Revenue (Million USD) of LFB Group 2017-2020e
76.Figure Intravenous Immunoglob
